Uceris · DIN 02498057 · 2 mg/Act · Rectal Foam-14 Act Canister
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Uceris · DIN 02498057
Manufacturer: Bausch Health Canada Inc.; listing date 2024-03-28
Health Canada: Marketed since 2023-09-18 · brand UCERIS · ATC A07EA06 BUDESONIDE · form Foam · route Rectal · ingredients BUDESONIDE 2 MG/ACT · company Bausch health, canada inc. · schedule Prescription
Uceris: Formulary list price $99.96 per unit (the source does not state the unit; exact figure $99.9600). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02498057)
Source record
DIN 02498057: Uceris
Raw flags: sec3=Y
Item: 564000142; group id 673; item number 1682; lccId None; manufacturer id BHC
Source form: Rectal Foam-14 Act Canister; strength: 2mg/Act
Recorded listing: General benefit
Source prices (unrounded): $99.9600; ministry $99.9600
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02498057
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98785
Shortage status: not checked (no credentials)